AMDOCS LIMITED (DOX): what the price assumes

boothcheck covers AMDOCS LIMITED (DOX) but does not put one priced-in number on it: here the defensible answer is the evidence rather than a point estimate. boothcheck publishes no house fair value, target price, or buy/sell rating. Narrative composed 2026-07-25.

Generated: 2026-09-07 · Exported: 2026-09-09 · Source: https://boothcheck.com/report/DOX

Headline

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

The operating-margin figure is value-band context at year 12: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

The price sits below what even a 5%/yr operating-profit decline would warrant; the inversion reports a bound, not a solved growth path.

Solve inputs: computed at a 8.1% cost of capital with 4% terminal growth over a 5-year stage.

How unusual the bet is: within-range (limited comparison data)

Valuation X-Ray

The price is supported by asset-based and earnings-power and relative-multiple and growth-DCF value. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

Families that justify the price: Asset, Earnings, Relative, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.7%); the inversion above states its own rate.

Per-Model Detail (n=19)

Solvency

Interest expense is not separately reported in the latest filings, so interest coverage cannot be computed.

Bullet Takeaways

• The contracted order book is larger than the whole company: the annual filing states that As of September 30, 2025, the aggregate amount of the transaction price allocated to remaining performance obligations that are unsatisfied or partially unsatisfied was approximately $6.4 billion.
• Revenue went backwards on purpose, falling 9.4% to $4,532.9 million in fiscal 2025 as Amdocs phased out low-margin, non-core work, so the headline decline and the underlying business are describing different things.
• Concentration is the standing risk: AT&T and T-Mobile each buy multiple services with a large portion of the work sitting inside managed-services contracts, which is why the cash flow is steady and why one renewal decision matters more here than at most software companies.

Bull Case

One number decides this company, and it is not on the income statement. In fiscal 2025 Amdocs generated 749.1 million dollars of cash from operations and spent 104.0 million dollars on capital expenditure, net, leaving roughly 645 million dollars after keeping the business equipped. Set that against a market value near 6.0 billion dollars and the arithmetic is straightforward. Hold that cash figure and almost nothing else in the debate matters. Halve it and nothing else can rescue the case. Everything below is about whether it holds.

The order book says it probably does. The filing reports that As of September 30, 2025, the aggregate amount of the transaction price allocated to remaining performance obligations that are unsatisfied or partially unsatisfied was approximately $6.4 billion. That is committed, non-cancelable work worth more than the entire equity is priced at, and it exists because of how the business is shaped. Managed-services arrangements are about two-thirds of what Amdocs sells, and the company describes the mechanism itself: We believe that our business model of developing mission-critical software, deploying it at our customers and then operating it and supporting it on an ongoing basis, provides Amdocs with a high level of recurring revenue. Selling a carrier its billing and customer systems is one transaction. Running those systems every day afterwards is an annuity.

The revenue decline that dominates the headline was a decision, not an accident. The filing is explicit: Revenue decreased by $472.1 million, or (9.4)%, to $4,532.9 million in fiscal year 2025, from $5,005.0 million in fiscal year 2024. In fiscal year 2025, we phased out several low margin, non-core business activities, the results of which were included in fiscal year 2024. Shedding the worst-priced work in a business that converts about 12.6% of revenue into operating profit raises the average even as the total falls. Revenue that leaves voluntarily takes very little profit with it.

The profitability comparison flatters Amdocs more than its size would suggest. DXC ran a 7.7% operating margin on $12.6 billion of revenue with revenue down 1.8% year over year; SAIC managed 7.9% on $7.29 billion with revenue down 2.9%; EPAM earned 9.7% on $5.56 billion; LDOS 12.0% on $17.3 billion. Only CTSH is clearly ahead, at 15.8% on $21.4 billion. Amdocs is earning at or above most of the IT-services field on a fraction of their scale, which is what specialization in one vertical is supposed to buy you.

Financing is close to a non-issue and the cash keeps going back to holders. Liquid assets sit near 514 million dollars against borrowings near 646 million dollars, a net position of about 0.2 times operating profit, and the filing reports net interest and other expense of just $38.4 million for fiscal 2025 against operating profit near $629 million. On August 2, 2023 the board authorized the repurchase of up to an additional $1.1 billion of ordinary shares with no expiration date; that authorization was exhausted during fiscal 2025 and repurchases began under a plan adopted in May 2025. The company has been buying its own shares steadily rather than announcing and stalling.

Bear Case

Start with who else is bidding for the same telecom IT budget. CTSH's own annual filing names its competitive set directly: Capgemini, CGI, Deloitte Digital, DXC Technology, EPAM Systems, Genpact, HCL Technologies, IBM Consulting, Infosys Technologies, Tata Consultancy Services and Wipro. Those firms are larger, several are far larger, and none of them needs to beat Amdocs at billing systems to hurt it. They need only convince a carrier that a modernization programme belongs with a general integrator rather than a specialist. Amdocs itself does not pretend the field is quiet: the filing states that The market for communications information systems is highly competitive and fragmented, and we expect competition to continue to increase. Among the factors it lists as deciding those contests is the effective and efficient integration of AI, including generative AI, into products and services. That is the disruption thesis in the company's own words, and it cuts against an incumbent whose defensive moat is the accumulated complexity of its installed systems. Tooling that reduces the cost of replacing complex software reduces the value of having installed it.

The customer list makes the problem concentrated rather than diffuse. AT&T and T-Mobile both buy multiple services, with a large portion of the relationship running through managed-services arrangements. That structure produces beautiful cash flow right up to the point where one of two counterparties decides to change direction. The recurring revenue is real; the number of decision-makers who control it is small.

Meanwhile the top line is contracting. Revenue fell 9.4% in fiscal 2025 to $4,532.9 million. The company attributes it to a deliberate exit from low-margin work, and that explanation is credible, but a business that has been restructuring in consecutive years is not simply pruning: restructuring charges ran $80.5 million in fiscal 2025 and $131.1 million in fiscal 2024. Two years of restructuring is a reorganization, not a tidy-up.

Now the awkward part of the valuation, which cuts the opposite way to how it first reads. Every family of method lands at or above today's price. Nothing finds this stock expensive. When no standard frame objects to a price, the market is usually pricing something the frames do not carry, and here the obvious candidate is terminal risk rather than near-term earnings: a customer universe of a few dozen large carriers, in an industry that consolidates, being courted by competitors with more capital and louder AI stories. Cheapness on trailing cash flow is not protection against a shrinking addressable base.

There is also nothing behind the operating business to fall back on. Amdocs holds no material equity stakes outside its operations, borrowings and cash roughly offset each other, and the balance sheet is neither a risk nor a cushion. What the holder owns is the contract book and the renewal rate, and nothing else.

Valuation

The unusual thing about Amdocs is not how the methods disagree. It is that they do not. Every family, from asset value through earnings power and comparable multiples to the forward cash-flow read, lands at or above today's price of $51.99. That almost never happens, and it is the single most informative fact available about the stock.

Working from the price back to the assumption behind it gives the same answer. At the current price the market is paying about ten times the operating profit of the last twelve months, a level low enough that the price sits below what even a 5% a year decline in operating profit would warrant. That is a bound rather than a forecast: the price does not need growth, and it does not need flat performance either. It leaves room for the business to shrink.

Two of the reads deserve the reader's attention because they are built on cash rather than accounting. Capitalizing normalized operating profit, roughly $0.67 billion averaged over five years, at the cost of capital with no growth assumed at all produces a value essentially equal to today's price. Capitalizing free cash flow as a flat perpetuity does much the same. In plain terms, today's price is close to what the company is worth if it never grows again, which is a reasonable description of what the last fiscal year actually looked like.

Cohort position agrees. The multiple sits in the lower part of the range the comparable IT-services group trades in, and that is on a company earning better operating margins than most of them: 12.6% against 7.7% for DXC, 7.9% for SAIC and 9.7% for EPAM, with CTSH at 15.8%. A lower multiple on a better margin is either an opportunity or a market verdict about the durability of the customer base. Both readings are live.

Solvency neither helps nor hinders. Liquid assets near 514 million dollars sit against borrowings near 646 million dollars, so the net position is about 0.2 times operating profit, and net interest and other expense of $38.4 million in fiscal 2025 barely registers against operating profit near $629 million. The reason the arithmetic looks generous is not that the balance sheet is doing work. It is that the market has decided the contract book is worth less than its own filed value, and the methods, all four of them, disagree.

Catalysts

The next scheduled report is August 5, 2026, and it follows fiscal second-quarter results published on May 22, 2026. Commercially, the most concrete recent item is a strategic multi-year agreement with Telefonica Moviles Argentina for a modernization programme, announced on May 14, 2026. New multi-year modernization work is exactly the kind of contract that feeds the committed order book, so the August print is the first chance to see whether the contracted balance is rebuilding after the deliberate revenue exits.

Sell-side sentiment has moved the other way over the same stretch. In early June 2026 two firms lowered their price targets while keeping buy ratings on the stock, and on June 28, 2026 CFRA downgraded the shares to sell from hold. Worth holding those two facts together: the valuation frames in this report all sit at or above the traded price while the sell-side has been marking its expectations down. That combination is what a de-rating looks like when the cash generation has not yet cracked. Which one is early is the open question.

On the filing side, the items to track are already dated. The annual report, published December 15, 2025, put contracted remaining performance obligations at approximately $6.4 billion as of September 30, 2025, and disclosed that the deliberate exit from thinly priced, non-core activities drove the 9.4% revenue decline for the year. The repurchase authorization approved on August 2, 2023 for up to an additional $1.1 billion was fully used during fiscal 2025, with buying continuing under a plan adopted in May 2025. Whether the August report shows the contracted balance holding near that level is the cleanest single test of the thesis available this year.

Peer Cohorts (Per Segment, With Filing Citations)

Core business (reported)

• WIT (WIPRO LIMITED)
• (no filing in the citation store)
• CTSH (COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION)
• FY2025 10-K: , Capgemini, CGI, Deloitte Digital, DXC Technology, EPAM Systems, Genpact, HCL Technologies, IBM Consulting, Infosys Technologies, Tata Consultancy Services and Wipro. In addition, we compete with numerous smaller local companies in the various geographic markets in which we operate. For additional information, see…
• FY2025 10-K: …our business and costs of operations. As a developing country, India has experienced and may continue to experience high inflation and wage growth, fluctuations in gross domestic product growth and volatility in currency exchange rates, any of which could materially adversely affect our cost of operations.…
• EPAM (EPAM SYSTEMS, INC.)
• FY2025 10-K: …operations. If we are unable to compete successfully against others in our industry, pricing pressures or loss of market share could have a material adverse effect on our business. The market for our services is highly competitive and we expect competition to persist and intensify, especially as we and our…
• FY2025 10-K: …in the Fortune 1000 and to be included as a leader in the IDC MarketScapes for Worldwide Experience Build Services and Worldwide Experience Design Services. Competition The markets in which we compete are changing rapidly and we face competition from multiple market participants such as other global technology…
• KD (Kyndryl Holdings, Inc.)
• FY2025 10-K: …and integrate such innovations with sufficient speed and versatility, we could fail in our ongoing efforts to maintain and increase our revenue and profit margins, achieve and sustain our targeted growth rates or improve our market share, operating margins and competitive position generally or in specific markets or…
• FY2025 10-K: …compared to the year ended March 31, 2023, including a favorable currency exchange rate impact of three points. The revenue decline was largely attributable to actions the Company has taken to reduce low-margin components of its customer relationships. Adjusted EBITDA increased $158 million from the prior year,…
• DXC (DXC Technology Co)
• FY2025 10-K: …variations do not materially affect our long-term performance, they may contribute to periodic fluctuations in revenue, expenses, and profitability. We continue to monitor these trends and adjust our operations as needed to optimize performance throughout the year. Competition The IT and professional services markets…
• FY2025 10-K: …alliance partners, our business and results of operations could be adversely affected. We face aggressive price competition and may have to lower prices to stay competitive, while simultaneously seeking to maintain or improve revenue and gross margin. This price competition may continue to increase from emerging…
• IBM (INTERNATIONAL BUSINESS MACHINES CORP)
• FY2025 10-K: …33.1 % 32.1 % 1.0 pts. Software gross profit margin of 83.5 percent in 2025 decreased 0.2 points compared to the prior year. Segment profit of $9,920 million increased 14.2 percent and segment profit margin of 33.1 percent increased 1.0 points compared to the prior year. The year-to-year increases in segment profit…
• FY2025 10-K: …revenue percent change for Strategy and Technology and Intelligent Operations. These changes did not impact our Consolidated Financial Statements or our reportable segments. The following table presents each reportable segment's revenue and gross margin results, followed by an analysis of the 2025 versus 2024…
• LDOS (Leidos Holdings, Inc.)
• FY2025 10-K: …acquisitions of businesses or establish teaming or other agreements among themselves or third parties, which could allow them to offer more competitive and comprehensive solutions. As a result of such acquisitions or arrangements, our current or potential competitors may be able to accelerate the adoption of new…
• FY2025 10-K: …revenues and growth prospects. Our business is highly competitive, and we compete with larger companies with greater name recognition, financial resources, and a larger technical staff. We also compete with smaller, more specialized companies that can concentrate their resources on particular areas. Additionally, we…
• SAIC (Science Applications International Corporation)
• FY2025 10-K: …Condition and Results of Operations" in Part II, Item 7 of this report. Competition Competition for contracts is intense, and we often compete against a large number of established multinational companies, which may have greater name recognition, financial resources and larger technical staffs than we do. We also…
• FY2025 10-K: …more profitable. Changes in cost of revenues as a percentage of revenues other than from revenue volume or cost mix are normally driven by fluctuations in shared or corporate costs, or cumulative revenue adjustments due to changes in estimates. Changes in operating cash flows are described with regard to changes in…

Methodology Note

• Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
• Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
• Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
• Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.